NASDAQ:APRE | EBITDA | Aprea Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$3.42M
2025-12-31-$2.64M
2025-03-31-$4.08M
2024-12-31-$3.22M
2024-03-31-$3.14M
2023-12-31-$3.67M
2023-03-31-$4.62M
2022-12-31-$2.65M

Annual EBITDA

DateEBITDA
2025-12-31-$13.21M
2024-12-31-$14.3M
2023-12-31-$15.46M
2022-12-31-$113.39M
2021-12-31-$37.43M